rejecting adverse finding regarding symptom claims premised on the absence of significant pain therapy where the claimant took prescription pain medications including narcotic analgesics
How later courts described this case
- rejecting adverse finding regarding symptom claims premised on the absence of significant pain therapy where the claimant took prescription pain medications including narcotic analgesics
- “Impairments that can be controlled effectively with medication are not disabling.”
- “[T]he Commissioner may not discredit [a] claimant’s testimony as to the severity of symptoms merely because they are unsupported by objective medical evidence.”
- discussing the five-step evaluation in detail
Written by the judges who cited it.
The opinion
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF OREGON
TONI D., No. 6:24-cv-00867-AR
Plaintiff, OPINION & ORDER
v.
COMMISSIONER, SOCIAL
SECURITY ADMINISTRATION,
Defendant.
ARMISTEAD, United States Magistrate Judge
In this judicial review of the Commissioner’s final decision denying Social Security
benefits, plaintiff Toni D. (her last name omitted for privacy) challenges the Administrative Law
Judge’s (ALJ) evaluation of her symptom allegations. As discussed below, the Commissioner’s
decision is reversed, and this case is remanded for further proceedings consistent with this
opinion.1
ALJ’s DECISION
Plaintiff applied for Title XVI Supplemental Security Income (SSI) on February 23,
2021, alleging disability beginning on the application date. (Tr. 224.) Her claims were first
denied on September 28, 2021, and again upon reconsideration on August 11, 2022. (Tr. 113,
128.) The ALJ held a hearing on June 20, 2023. (Tr. 32-58.)
In denying plaintiff’s applications, the ALJ followed the five-step sequential evaluation
process.2 At step one, the ALJ determined plaintiff had not engaged in substantial gainful activity
since February 23, 2021, her alleged onset date. (Tr. 20.) At step two, the ALJ determined that
plaintiff had the severe impairments of schizoaffective disorder; PTSD; anxiety; chronic
obstructive pulmonary disease; lumbar degenerative disc disease; obstructive sleep apnea; and
obesity were severe impairments. (Tr. 20.) At step three, the ALJ determined that plaintiff’s
impairments singly or in combination did not meet or medically equal the severity of any listed
impairment. (Tr. 20.)
The ALJ then determined that plaintiff had the residual functional capacity (RFC), 20
C.F.R. § 416.945, to perform a reduced range of light work with the following limitations:
[S]he can occasionally climb ramps and stairs but can never climb ladders, ropes
or scaffolds. She can frequently balance and occasionally stoop, kneel, crouch,
and crawl. The claimant can tolerate no exposure to extreme cold or vibration.
1 This court has jurisdiction under 42 U.S.C. §§ 405(g) and 1383(c)(3), and all parties have
consented to jurisdiction by magistrate judge under Federal Rule of Civil Procedure 73 and 28
U.S.C. § 636(c).
2 To determine a claimant’s disability, the ALJ must apply a five-step evaluation. See 20
C.F.R. §§ 404.1520(a)(4), 416.920(a)(4). If the ALJ finds that a claimant is either disabled or not
disabled at any step, the ALJ does not continue to the next step. Id.; see also Parra v. Astrue, 481
F.3d 742, 746–47 (9th Cir. 2007) (discussing the five-step evaluation in detail).
She can tolerate moderate exposure to pulmonary irritants. She is able to
understand, remember, carryout and persist at simple, routine tasks. She is able to
make simple, work-related decisions. The claimant is incapable of performing
assembly line paced work. She is capable of occasional contact with the general
public and occasional interaction with coworkers.
(Tr. 22.)
At step four, the ALJ determined that plaintiff has no past relevant work. (Tr. 25.) Given
her age, education, work experience, and RFC, the ALJ found at step five that jobs exist in
significant numbers in the national economy that plaintiff can perform, including such
representative occupations as office helper, mail room clerk, and photocopy machine operator.
(Tr. 26.) The ALJ therefore concluded that plaintiff was not disabled from February 23, 2021,
the alleged onset date, through the date of decision. (Tr. 26.)
STANDARD OF REVIEW
The district court must affirm the Commissioner’s decision if the Commissioner applied
proper legal standards and the findings are supported by substantial evidence in the record. 42
U.S.C. § 405(g); Ford v. Saul, 950 F.3d 1141, 1154 (9th Cir. 2020). Substantial evidence is
“more than a mere scintilla” and is “such relevant evidence as a reasonable mind might accept as
adequate to support a conclusion.” Biestek v. Berryhill, 587 U.S. 97, 103 (2019) (quotation and
citation omitted). To determine whether substantial evidence exists, the court must weigh all the
evidence, whether it supports or detracts from the Commissioner’s decision. Garrison v. Colvin,
759 F.3d 995, 1009 (9th Cir. 2014).
DISCUSSION
Plaintiff argues that the ALJ erred by failing to provide clear and convincing reasons for
discounting her subjective symptom testimony. At the administrative hearing on May 3, 2022,
plaintiff said that her back, leg, and hip pain stopped her from walking more than two blocks,
depending on the day and the weather. (Tr. 44-45.) She could sit for about 30 minutes. (Tr. 45.)
Her back would start hurting if she tried to lift more than a gallon of milk. (Tr. 45.) She typically
had pain at about 7/10. (Tr. 47.) Being active would increase her pain. (Tr. 47.) Plaintiff had
been taking Lyrica for her nerve pain since December 2021. (Tr. 43.)
Determining the credibility of a claimant’s testimony regarding subjective reports of pain
or symptoms requires the ALJ to undertake a two-step process of analysis. Trevizo v. Berryhill,
871 F.3d 664, 678 (9th Cir. 2017). In the first stage, the claimant must produce objective medical
evidence of an underlying impairment that could reasonably be expected to produce the alleged
symptoms. Treichler v. Comm’r Soc. Sec. Admin., 775 F.3d 1090, 1102 (9th Cir. 2014);
Tommasetti v. Astrue, 533 F.3d 1035, 1039 (9th Cir. 2008). At the second stage, if there is no
affirmative evidence of malingering, the ALJ must provide specific, clear and convincing
reasons for discounting the claimant’s testimony. Brown-Hunter v. Colvin, 806 F.3d 487, 488-89
(9th Cir. 2015); 20 C.F.R. § 404.1529. The specific, clear and convincing standard is “the most
demanding required in Social Security cases” and is “not an easy requirement to meet.”
Garrison, 759 F.3d at 1015; Trevizo, 871 F.3d at 678-79. The “clear and convincing” standard
requires an ALJ to “show [their] work” but, ultimately, the question is not whether the ALJ’s
rationale convinces the court, but whether the ALJ’s rationale “is clear enough that it has the
power to convince.” Smartt v. Kijakazi, 53 F.4th 489, 499 (9th Cir. 2022).
The ALJ found plaintiff’s medically determinable impairments could reasonably be
expected to cause the alleged symptoms and did not identify evidence of malingering. (Tr. 23.)
But the ALJ concluded that plaintiff’s statements concerning the intensity, persistence and
limiting effects of her symptoms were not entirely consistent with the medical evidence and
other evidence in the record. (Tr. 23.) The ALJ discounted certain limited aspects of plaintiff’s
symptom allegations because they conflicted with objective medical evidence in the record, and
other evidence of her improvement with conservative treatment. (Tr. 23-25.)
A. Inconsistency with Objective Medical Evidence
Plaintiff argues that the ALJ’s decision to discount her testimony about the significance
of her lumbar spine impairments is not supported by substantial evidence, and fails to explain the
inconsistency between plaintiff’s allegations and the medical evidence with any specificity. (Pl.
Br. at 6-12.)
To evaluate the intensity, persistence, and limiting effects of a claimant’s symptoms, an
ALJ considers 1) daily activities; 2) the location, duration, frequency, and intensity of pain or
other symptoms; 3) factors that precipitate and aggravate the symptoms; 4) the type, dosage,
effectiveness, and side effects of any medication an individual takes or has taken to alleviate pain
or other symptoms; 5) treatment, other than medication, an individual receives or has received
for relief of pain or other symptoms; 6) any measures other than treatment an individual uses or
has used to relieve pain or other symptoms; and 7) any other factors concerning an individual’s
functional limitations and restrictions based on pain or other symptoms. SSR 16-3p, 2017 WL
5180304, at *9 (effective October 25, 2017); 20 C.F.R. § 404.1529(c). An ALJ may consider
whether symptom testimony is consistent with objective medical evidence. Id. at *7-8. Even so, a
lack of objective medical evidence may not form the sole basis for discounting a claimant’s
testimony. Reddick v. Chater, 157 F.3d 715, 722 (9th Cir. 1998) (“[T]he Commissioner may not
discredit [a] claimant’s testimony as to the severity of symptoms merely because they are
unsupported by objective medical evidence.”). But when coupled with other permissible reasons,
lack of corroborating objective medical evidence may discount claimant’s testimony. Batson v.
Comm’r Soc. Sec. Admin., 359 F.3d 1190, 1197-98 (9th Cir. 2004)). Furthermore, “[w]hen
objective medical evidence in the record is inconsistent with the claimant's subjective testimony,
the ALJ may indeed weigh it as undercutting such testimony.” Smartt v. Kijakazi, 53 F.4th 489,
498 (9th Cir. 2022).
Because the ALJ failed to identify objective medical evidence that directly conflicted
with plaintiff’s testimony about limitations stemming from her back pain, she did not offer a
clear and convincing reason for discounting it. Conflict with objective medical evidence can be a
sufficient basis for discounting a claimant’s testimony. Smartt, 53 F.4th at 498; 20 C.F.R. §
416.929(c)(2). At the hearing, plaintiff testified that she could only walk a few blocks at a time,
could only sit for about 30 minutes, and typically had significant back pain – about 7/10. (Tr. 44-
47.) The ALJ only cited one conflict between the medical record and plaintiff’s allegations of
severe back pain. In her consideration of the persuasiveness of medical opinions in the record
(not the discussion of what evidence undermined plaintiff’s testimony), the ALJ noted that prior
administrative medical findings were consistent with “imaging of the claimant’s lumbar spine
showing postoperative and mild degenerative changes of the lumbar spine.” (Tr. 24 (citing Tr.
561).) These records show the results of March, 2020 back imaging, but make no comment on
the pain or physical limitations plaintiff suffers as a result of her back issues. (See Tr. 560.) The
bulk of plaintiff’s testimony described the difficulties caused by her back pain, which does not
conflict with the imaging the ALJ cites. (Compare Tr. 44-47 with Tr. 560.) The evidence on
which the ALJ relies does not conflict with plaintiff’s symptom testimony and is not a clear and
convincing reason to discount plaintiff’s allegations.
The ALJ also did not state her reasoning with sufficient specificity. When discounting
symptom testimony, an ALJ’s decision “must be sufficiently specific to allow a reviewing court
to conclude the adjudicator rejected the claimant’s testimony on permissible grounds and did not
arbitrarily discredit a claimant’s testimony regarding pain.” Bunnell v. Sullivan, 947 F.2d 341,
345 (9th Cir. 1991) (citation and internal quotation marks omitted). In this context, that means an
ALJ must “identify the testimony she found not credible,” and “link that testimony to the
particular parts of the record supporting her non-credibility determination.” Brown-Hunter v.
Colvin, 806 F.3d 487, 494 (9th Cir. 2015).
When considering plaintiff’s testimony, the ALJ failed to meaningfully connect the dots.
The ALJ devotes only a paragraph to plaintiff’s symptom testimony, and fails to provide any
analysis (there or elsewhere) about how the medical records cited in the written opinion
undermine plaintiff’s specific testimony about difficulty walking, standing, lifting, or the extent
of her pain. (See Tr. 24.) That does not live up to the Ninth Circuit’s expectation that an ALJ
identify which of a plaintiff’s statements or what testimony is supposedly undermined by the
record, and what parts of the record undermine it. Brown-Hunter, 806 F.3d at 494. It is unclear
how the ALJ’s cited medical records conflict with testimony such as plaintiff’s inability to walk
more than two blocks or sit for over thirty minutes. (Tr. 44-47.) That leaves this reviewing court
to surmise which “testimony [the ALJ] found not credible” and what “particular parts of the
record supporting h[is] non-credibility determination.” Brown-Hunter, 806 F.3d at 494. Failure
to provide such clear analysis is error, and the court therefore finds the ALJ failed to give a
sufficiently clear and convincing reason for discounting plaintiff’s symptom testimony. On
remand, the ALJ must be more explicit about what testimony is being discounted and why.
\ \ \ \ \
\ \ \ \ \
B. Improvement with Treatment3
The ALJ also relied on records showing plaintiff’s symptoms improved with treatment
when concluding that her symptom testimony overstated her limitations. An ALJ may reject a
claimant’s symptom testimony if that testimony is contradicted by evidence in the medical
record. Carmickle v. Comm'r of Soc. Sec. Admin., 533 F.3d 1155, 1161 (9th Cir. 2008). If the
record shows a claimant’s symptoms have improved with treatment, that improvement is “an
important indicator of the intensity and persistence of ... symptoms.” 20 C.F.R. §§
404.1529(c)(3), 416.929(c)(3); Wellington v. Berryhill, 878 F.3d 867, 876 (9th Cir. 2017) (noting
“evidence of medical treatment successfully relieving symptoms can undermine a claim of
disability”). Symptom improvement, however, must be weighed within the context of an “overall
diagnostic picture.” Holohan v. Massanari, 246 F.3d 1195, 1205 (9th Cir. 2001).
The ALJ again failed to provide a clear and convincing reason to discount plaintiff’s
symptom testimony when she concluded that her allegations of back pain and associated
limitations were overstated because these issues improved with treatment. Even though evidence
that treatment improves a claimant’s symptoms can be a clear and convincing reason for
discounting a plaintiff’s symptom testimony, Wellington, 878 F.3d at 876, an ALJ must view it
3 Although not clearly stated in the written opinion, defendant suggests that the ALJ also
discounted plaintiff’s symptom testimony because she “was able to manage her back pain with
opioid medication.” Def. Br. at 3 (citing 20 C.F.R. § 416.929(c)(3)(iv)–(v) and Warre v. Comm’r
of Soc. Sec., 439 F.3d 1001, 1006 (9th Cir. 2006) (“Impairments that can be controlled
effectively with medication are not disabling.”). This is not a case where plaintiff’s treatment
was “conservative,” and if the ALJ indeed relied on that basis to discount plaintiff’s testimony,
her conclusion was not supported by substantial evidence. Courts in this district have
consistently found that a claimant taking narcotic pain medication (like plaintiff) is not receiving
“conservative treatment.” See, e.g., Yolanda G. v. Kijakazi, 2022 WL 336841, at *5 (D. Or. Feb.
4, 2022); see also Kager v. Astrue, 256 F. App'x 919, 923 (9th Cir. 2007) (rejecting adverse
finding regarding symptom claims premised on the absence of significant pain therapy where the
claimant took prescription pain medications including narcotic analgesics).
in context, “with an understanding of the patient’s overall well-being and the nature of her
symptoms,” Attmore v. Colvin, 827 F.3d 872, 877 (9th Cir. 2016). The record is mixed on the
extent to which medication improved plaintiff’s back symptoms. As the ALJ noted, plaintiff
treated her back pain “with medication management,” and previously shared with medical
professionals that “her back pain was improving” on opioid pain medication in 2021. (Tr. 23.) As
the ALJ further acknowledges, however, plaintiff’s opioid medication was discontinued in 2022.
(Tr. 23 (citing Tr. 630).) Nor do the records the ALJ cited showing plaintiff reported back pain
“improving” on opioids address whether plaintiff could walk, lift, or sit for more than 30
minutes. (Tr. 23 (citing Tr. 315).) Without more, the court cannot conclude that the ALJ
supported the decision to discount plaintiff’s symptom testimony about her back pain with
substantial evidence. On remand, the ALJ should be more specific about what testimony the
evidence of improvement on opioid pain undermines, why, and the time period that it applies to.
C. Remand for Further Proceedings
Within the court’s discretion under 42 U.S.C. § 405(g) is the “decision whether to
remand for further proceedings or for an award of benefits.” Holohan v. Massanari, 246 F.3d
1195, 1210 (9th Cir. 2001) (citation omitted). Although a court should generally remand to the
agency for additional investigation or explanation, a court has discretion to remand for
immediate payment of benefits. Treichler v. Comm’r Soc. Sec. Admin., 775 F.3d 1090, 1099-100
(9th Cir. 2014). The issue turns on the utility of further proceedings. A court may not award
benefits punitively and must conduct a “credit-as-true” analysis on evidence that has been
improperly rejected by the ALJ to determine whether a claimant is disabled under the Social
Security Act. Strauss v. Comm’r Soc. Sec. Admin., 635 F.3d 1135, 1138 (9th Cir. 2011).
In the Ninth Circuit, the “credit-as-true” doctrine is “settled” and binding on this court.
Garrison, 759 F.3d at 999. The court first determines whether the ALJ made a legal error and
then reviews the record as a whole to determine whether the record is fully developed, the record
is free from conflicts and ambiguities, and there is any useful purpose in further proceedings.
Dominguez v. Colvin, 808 F.3d 403, 407 (9th Cir. 2015). Only if the record has been fully
developed and there are no outstanding issues left to be resolved does the district court consider
whether the ALJ would be required to find the claimant disabled on remand if the improperly
discredited evidence were credited as true. Id. If so, the district court can exercise its discretion
to remand for an award of benefits. Id. The district court retains flexibility, however, and need
not credit statements as true merely because the ALJ made a legal error. Id. at 408.
The ALJ committed harmful error by failing to provide specific, clear, and convincing
reasons to reject plaintiff’s symptom testimony. After reviewing the record, however, conflicts
and ambiguities remain between the improperly rejected testimony and the evidence of the
severity and limiting effects of plaintiff’s back pain. Plaintiff herself asks for remand for further
consideration of the impact of her lumbar impairment on her ability to perform basic work
activities, and whether “Plaintiff was disabled as of her 50th birthday, if not before then through
application of the Medical-Vocational Guidelines.” Pl. Br. at 11. In reviewing plaintiff’s case
upon remand, the ALJ should re-examine the evidence which was improperly discounted and
reformulate the RFC if necessary, and seek further VE testimony at step five, if necessary. The
court remands for further proceedings.
\ \ \ \ \
\ \ \ \ \
CONCLUSION
For the reasons given above, the Commissioner’s decision is reversed and this case is
remanded for further proceedings consistent with this opinion.
IT IS SO ORDERED.
DATED: February 27, 2025.
_/s_/_ J_E_F__F_ A_R__M_I_S_T_E_A__D________________
Jeff Armistead
United States Magistrate Judge